Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.225
-0.015 (-1.21%)
At close: Jul 8, 2026, 4:00 PM EDT
1.240
+0.015 (1.22%)
After-hours: Jul 8, 2026, 5:26 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $84.25 million as of July 8, 2026. Its market cap has increased by 67.50% in one year.
Market Cap
84.25M
Enterprise Value
78.99M
1-Year Change
67.50%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $84.25M, a decrease of -59.35%. That is a compound annual growth rate of -31.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 84.25M | 84.25% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 89.57M |
| Seer, Inc. | 89.07M |
| MAIA Biotechnology | 88.16M |
| NeurAxis | 87.43M |
| Cardiff Oncology | 86.83M |
| Gossamer Bio | 84.67M |
| OS Therapies | 84.18M |
| Rallybio | 83.79M |